免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

酶填充針筒 - RELiZORB

K 號:K231156 · 2023-08-30

決定日期2023-08-30
產品代碼PLQ
諮詢委員會GU
決定相當於

器材摘要

Enzyme Packed Cartridge - RELiZORB is the device name listed in this FDA 510(k) record. The listed applicant is Alcresta Therapeutics, Inc.. It received FDA 510(k) clearance on 2023-08-30 under 510(k) number K231156. The device is classified under product code PLQ. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the Enzyme Packed Cartridge - RELiZORB?

Enzyme Packed Cartridge - RELiZORB is a medical device that received FDA 510(k) clearance on 2023-08-30. The listed applicant is Alcresta Therapeutics, Inc.. The 510(k) number is K231156.

When did Enzyme Packed Cartridge - RELiZORB receive FDA 510(k) clearance?

Enzyme Packed Cartridge - RELiZORB received FDA 510(k) clearance on 2023-08-30, under 510(k) number K231156.

Who is the listed applicant for Enzyme Packed Cartridge - RELiZORB?

The FDA 510(k) record lists Alcresta Therapeutics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Enzyme Packed Cartridge - RELiZORB?

The FDA product code for Enzyme Packed Cartridge - RELiZORB is PLQ.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Alcresta Therapeutics, Inc. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

查看所有 7 項裝置 →

相關器械(代碼:PLQ)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑